Archives
|
Entry
|
Blogger
|
Date
|
Location
|
|
What’s Your Breakthrough Idea? Let’s Talk About How to Change the World on March 29
|
Gregory T. Huang |
02/09/10 |
Seattle
|
|
San Diego’s Halozyme Therapeutics Seeks Biotech Cure for Cellulite
|
Denise Gellene |
02/09/10 |
San Diego
|
|
Infinity’s New CEO, Veteran Dealmaker, Seeks to Deliver on Company’s Early Promise
|
Luke Timmerman |
02/09/10 |
Boston
|
|
Tragara Raises $5M
|
Bruce V. Bigelow |
02/08/10 |
San Diego
|
|
Cell Therapeutics Shares Fall as FDA Says Lymphoma Drug Has “Substantial” Side Effects
|
Luke Timmerman |
02/08/10 |
Seattle
|
|
Solace Pharma Closes Boston-Area Office After Pain Treatment Fails in Clinical Trial
|
Ryan McBride |
02/08/10 |
Boston
|
|
Verdezyne Identifies First Product
|
Bruce V. Bigelow |
02/08/10 |
San Diego
|
|
Optimer Rises on Takeover Buzz and Clinical Trial Results; Still Faces Business Risks
|
Luke Timmerman |
02/08/10 |
San Diego
|
|
Zafgen’s Mysterious Weight Loss Drug Advances Into First Trial for Obese Women
|
Luke Timmerman |
02/08/10 |
Boston
|
|
Ironwood Goes Public, Glasshouse and BG Medicine Aim to Do the Same, Vivox Collects $6.8M, & More Boston-Area Deals News
|
Rebecca Zacks |
02/05/10 |
Boston
|
|
Optimer Passes Second Big Trial of Drug for Deadly Bacteria
|
Luke Timmerman |
02/04/10 |
San Diego
|
|
Alkermes Unveils Cheaper, Easier Technique for Making Drugs Last Longer in Blood
|
Luke Timmerman |
02/04/10 |
Boston
|
|
Carl Icahn Nominates Scripps Researcher to Biogen Idec Board, BrainCells Pursues New Drug Combo for Depression, Illumina Adds to Oxford Nanopore Investment, & More San Diego Life Sciences News
|
Bruce V. Bigelow |
02/04/10 |
San Diego
|
|
Cell Therapeutics Nears Judgment Day, AVI Biopharma Awaits Results, HemaQuest Gets $6M & More Seattle-Area Life Sciences News
|
Luke Timmerman |
02/04/10 |
Seattle
|
|
Seattle Needs an “Incubator” Culture
|
Matthew Scholz |
02/04/10 |
Seattle
|
|
BlueKai Brings In Big Money, Siemens Licenses HealthVault, Intellectual Ventures Buys Avistar Patents, & More Seattle-Area Deals News
|
Gregory T. Huang |
02/03/10 |
Seattle
|
|
$9M for Syndax Pharmaceuticals
|
Erin Kutz |
02/03/10 |
Boston
|
|
Ironwood Climbs 3.6 Percent on IPO Debut Day, Shows Investor Interest—Albeit Tepid—in Biotech
|
Luke Timmerman |
02/03/10 |
Boston
|
|
NanoString Adds Exec Chairman
|
Luke Timmerman |
02/03/10 |
Seattle
|
|
Seattle Genetics Starts Lymphoma Trial
|
Luke Timmerman |
02/03/10 |
Seattle
|
|
Google Pours “Incredible” Computing Power into Antibody Drug Discovery With Adimab
|
Luke Timmerman |
02/03/10 |
Boston
|
|
Cell Therapeutics FDA Panel Primer: What You Need to Know to Be Ready Next Week
|
Luke Timmerman |
02/03/10 |
Seattle
|
|
All Eyes On Ironwood IPO, Icahn Seeks Biogen Board Seats, Boston Scientific Settles with J&J, & More Boston-Area Life Sciences News
|
Erin Kutz |
02/03/10 |
Boston
|
|
BrainCells Inc. Maps Out Next Steps for Novel Depression Drug
|
Luke Timmerman |
02/02/10 |
San Diego
|
|
BioBehavioral Nabs $10M
|
Luke Timmerman |
02/01/10 |
Boston
|
|
Hemaquest Snaps Up $6M To Treat Sickle Cell, Other Blood Disorders
|
Luke Timmerman |
02/01/10 |
Seattle
|
|
In-Person Insights on Virtual Biotechs at Xconomy Dinner
|
Ryan McBride |
02/01/10 |
Boston
|
|
AVI Biopharma Eagerly Awaits Data on Muscular Dystrophy Drug
|
Luke Timmerman |
02/01/10 |
Seattle
|
|
Ironwood Gears Up for Biotech’s Biggest IPO in Years, Sending Ripple Effect Through Industry
|
Luke Timmerman |
02/01/10 |
Boston
|
|
Illumina Bets Again on Oxford Nanopore, Joins $28M Investment in Cheaper Gene Sequencing
|
Luke Timmerman |
02/01/10 |
San Diego
|
|
Page 1 of
79 |
next page » |
Business, life sciences, and technology news — covering Boston, Seattle, San Diego, and beyond.
© 2007-2009, Xconomy, Inc.
XCONOMY is a registered service mark of Xconomy, Inc.
All rights reserved.
Site designed by
Matthew Bouchard, produced by
Andrew Koyfman,
and powered by WordPress.
